Veeva Systems Inc (VEE.BE)
| Previous close | 186.50 |
| Open | 185.85 |
| Bid | 186.20 x 0 |
| Ask | 186.60 x 0 |
| Day's range | 185.85 - 185.85 |
| 52-week range | 150.45 - 214.90 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Veeva Launches AI Partner Program
Veeva Systems (NYSE: VEEV) today announced the Veeva AI Partner Program to provide partners with the advanced technology and support needed to integrate Generative AI (GenAI) solutions seamlessly with Veeva Vault applications.
- PR Newswire
Veeva Announces Vault CRM Campaign Manager
Veeva Systems (NYSE: VEEV) today announced Veeva Vault CRM Campaign Manager, a new industry-specific marketing application that simplifies and speeds non-personal promotion to healthcare professionals. Vault CRM Campaign Manager lives in the same Vault as Veeva Vault CRM and shares the same customer data, giving sales and marketing the effortless synchronization needed for true customer centricity. Through orchestrated campaigns, marketing users in Vault CRM work side by side with field CRM user
- PR Newswire
Biopharma Leaders Come Together at Veeva Commercial Summit to Advance Customer-Centric Engagement
Veeva Systems (NYSE: VEEV) today announced that leaders from Bayer, Genentech, Novo Nordisk, Takeda, and others will be among the keynote speakers at the 2024 Veeva Commercial Summit, May 7-8 in Boston. Commercial and medical affairs professionals will share how they are innovating across content, data and analytics, and customer interactions to advance the future of customer-centric engagement.
